Veness Adam M 4
4 · ACCELERON PHARMA INC · Filed Nov 12, 2021
Insider Transaction Report
Form 4
Veness Adam M
VP, General Counsel and Sec.
Transactions
- Exercise/Conversion
Common Stock
2021-11-09$29.37/sh+4,500$132,165→ 23,423 total - Exercise/Conversion
Option to Purchase Common Stock
2021-11-09−4,500→ 0 totalExercise: $29.37Exp: 2024-08-01→ Common Stock (4,500 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying this stock option award vested as to 25% of the shares on July 14, 2015 and the remaining shares vested in equal quarterly installments over the following three years thereafter.